Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.40 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.40 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.39 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | FABP4 | P15090 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25367926 | 0.88 | ECE1 (0.41) | PRMT1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL28236290 | 0.80 | PRMT1 (0.47) | PRMT1ADRA1AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL17234580 | 0.80 | PRMT1 (0.47) | PRMT1ADRA1AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL466337 | 0.80 | PRMT1 (0.47) | PRMT1ADRA1AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL1343529 | 0.80 | DDAH1 (0.53) | PRMT1ADRA1AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL19933297 | 0.78 | ADRA1A (0.47) | PRMT1ADRA1AATMPLA2G4ALMNA | |
| SCHEMBL2035521 | 0.74 | PRMT1 (0.54) | PRMT1ADRA1AGRIN2DGRIN3BGRIN1 | |
| SCHEMBL585705 | 0.74 | PRMT1 (0.55) | PRMT1ADRA1ALMNAEPHX2MAPK1 | |
| SCHEMBL8944734 | 0.73 | PRMT1 (0.59) | PRMT1ADRA1APLA2G4ALMNAEPHX2 | |
| SCHEMBL3280998 | 0.71 | PRMT1 (0.50) | PRMT1ADRA1AATMPLA2G4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12351543-B2 | Process for the preparation of a metastable crystal modification of N-(aminoiminomethyl)-2-aminoethanoic acid (IV) | ALZCHEM TROSTBERG GMBH (DE) | 2025-07-08 | — | — | US | disclosed |
| CN-115594615-B | N, N' -guanidinodiacetic acid | 澳泽化学特罗斯特贝格有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-113784947-B | Process (IV) for preparing metastable crystal modifications of N- (aminoiminomethyl) -2-glycine | 澳泽化学特罗斯特贝格有限公司 | 2023-09-29 | — | — | CN | disclosed |
| EP-3997065-B1 | METHOD FOR PRODUCING A METASTABLE CRYSTAL MODIFICATION OF N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID (IV) | ALZCHEM TROSTBERG GMBH (DE) | 2023-08-02 | — | — | EP | disclosed |
| CN-115594615-A | N, N' -guanidinodiacetic acid | 澳泽化学特罗斯特贝格有限公司（DE） | 2023-01-13 | — | — | CN | disclosed |
| US-20220289670-A1 | PROCESS FOR THE PREPARATION OF A METASTABLE CRYSTAL MODIFICATION OF N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID (IV) | ALZCHEM TROSTBERG GMBH (DE) | 2022-09-15 | — | — | US | disclosed |
| CN-113784947-A | Process (IV) for preparing metastable crystal modifications of N- (aminoiminomethyl) -2-aminoacetic acid | 澳泽化学特罗斯特贝格有限公司 | 2021-12-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351543-B2 | Process for the preparation of a metastable crystal modification of N-(aminoiminomethyl)-2-aminoethanoic acid (IV) | ALAD, AADAT, DNPEP | PRMT1 2149/4885ADRA1A 1354/4885GRIN2D 487/4885 |
| US-20220289670-A1 | PROCESS FOR THE PREPARATION OF A METASTABLE CRYSTAL MODIFICATION OF N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID (IV) | ALAD, AADAT, DNPEP | PRMT1 2149/4885ADRA1A 1354/4885GRIN2D 487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.